Registry of Lobbyists

Registration - Consultant

ABBOTT LABORATORIES CANADA / Elsa Koutsavakis, Consultant

Registration Information

Client name: ABBOTT LABORATORIES CANADA
Lobbyist name: Elsa Koutsavakis, Consultant
Initial registration start date: 2006-10-17
Registration status: Inactive
Registration Number: 781329-13826

Version 2 of 3 (2007-05-07 to 2007-11-19)

Version 2 of 3 (2007-05-07 to 2007-11-19) was submitted prior to the Lobbying Act coming into force on July 2, 2008. Due to different information requirements at that time, the registration is presented in the following format.

A. Registrant

Consultant lobbyist name: Elsa Koutsavakis    Lobbyist business address
Consulting firm: GLOBAL PUBLIC AFFAIRS
50 O'Connor Street
Suite 901
Ottawa, ON  K1P 6L2
Canada
Position: Research Consultant
Telephone number: 613-783-3438  
Fax number: 613-782-2428  
 
Former public office holder: No
Payment is contingent on the success of the undertaking: No

B. Information about Client

Client: ABBOTT LABORATORIES CANADA
8401 TRANSCANADA HWY.
ST LAURENT, QC  H4S 1Z1
Canada
Telephone number: 514-832-7126
 
Client Representative: LAURIE DOTTO
 
The client is a subsidiary of the following parent companies: ABBOTT DIABETES CARE INC.
1360 S. LOOP RD. SUITE 2000
ALAMEDA, CA
United States of America 94502

ABBOTT GMBH & CO. KG
KNOLLSTRASSE 50
LUDWIGSHAFEN 67061
Germany

ABBOTT LABORATORIES
100 ABBOTT PARK ROAD
ABBOTT PARK, IL
United States of America 60064

ABBOTT SPINE
5301 RIATA PARK CT.
BUILDING F
AUSTIN, TX
United States of America 78727

ROSS PRODUCTS DIVISION
6480 BUSCH BLVD.
COLUMBUS, OH
United States of America 43229

TAP PHARMACEUTICAL PRODUCTS
675 NORTH FIELD DRIVE
LAKE FOREST, IL
United States of America 60045

VYSIS INC.
1300 E. TOUHY
DES PLAINS, IL
United States of America 60018

Coalition: The client is not a coalition.
Subsidiary: The client does not have any subsidiaries that could be affected by the outcome of the undertaking.
Individual, organization or corporation: The client's activities are not controlled or directed by another individual, organization or corporation with a direct interest in the outcome of this undertaking.
 
Was the client funded in whole or in part by any domestic or foreign government institution in the last completed financial year? No
 

C. Lobbying Activity Information

Federal departments or organizations which have been or will be communicated with during the course of the undertaking: Foreign Affairs and International Trade Canada (DFAITC), Health Canada (HC), Industry Canada, Patented Medicine Prices Review Board (PMPRB)
Communication techniques that have been used or are expected to be used in the course of the undertaking:
Informal communications, Meetings, Presentations, Telephone calls, Written communications, whether in hard copy or electronic format
 
Subject Matter: Areas of Concern: Consumer Issues, Health, Industry, Intellectual Property, International Relations, International Trade, Science and Technology
 

Details Regarding the Identified Subject Matter

Categories Description
Policy or Program CANADIAN AGENCY FOR DRUGS & TECHNOLOGIES IN HEALTH
Policy or Program CANADIAN OPTIMAL MEDICATION PRESCRIPTION AND UTILIZATION SERVICE
Policy or Program COMMON DRUG REVIEW
Policy or Program DRUG PRICE CONTROL
Policy or Program FEDERAL PUBLIC DRUG PLANS
Legislative Proposal, Regulation FOOD AND DRUG ACT AND REGULATIONS
Policy or Program INTERNET PHARMACY
Policy or Program NATIONAL PHARMACEUTICALS STRATEGY
Policy or Program NATIONAL PRESCRIPTION DRUG UTILIZATION INFORMATION SYSTEM
Legislative Proposal PATENT ACT




Date Modified: